Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 6 Lung Neoplasms 5 Breast Neoplasms 5 Prostatic Neoplasms 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Gastrointestinal Neoplasms 2 Uterine Cervical Neoplasms 1 Support of the Family as a Caregiving System 1 Stomach Neoplasms 1 Sarcoma 1 Quality of Life 1 Pseudomyxoma Peritonei 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pain 1 Ovarian Neoplasms 1 Otorhinolaryngologic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Mixed Dementias 1 Mesothelioma, Malignant 1 Meningeal Carcinomatosis 1 Maxillary Sinus Neoplasms 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Follicular 1

Interventions

Carboplatin 784 Pemetrexed 607 Cisplatin 545 Paclitaxel 491 pembrolizumab 464 Docetaxel 440 Gemcitabine 328 Erlotinib Hydrochloride 307 Radiotherapy 258 Nivolumab 244 Bevacizumab 233 osimertinib 178 Drug Therapy 164 durvalumab 157 atezolizumab 135 Gefitinib 134 Radiosurgery 133 Vinorelbine 111 Cetuximab 97 130-nm albumin-bound paclitaxel 94 Ipilimumab 86 Magnetic Resonance Spectroscopy 84 Taxes 79 Surgical Procedures, Operative 74 Afatinib 68 Albumin-Bound Paclitaxel 66 Specimen Handling 61 Etoposide 61 Cyclophosphamide 60 tislelizumab 59

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Referral and Consultation × Clear all

NCT06068088 2023-10-05

LUNGDIET

Assistance Publique - Hôpitaux de Paris

Carcinoma, Non-Small-Cell Lung, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡